MeSH tree: D09.400.430
Leukemia is adept at dodging the immune system, making it resistant to many of the newest generation of cancer immunotherapies. Now, researchers have identified a key part of the cancer's disguise: a protein called CD43 on ...
Apr 10, 2026
0
9
Polycystic ovary syndrome, or PCOS, affects as many as 18% of all childbearing-age women. The condition occurs when a woman's body produces too much of a group of hormones called androgens, chiefly testosterone. Menstrual ...
Apr 4, 2026
0
24
Fibrosis is the body's way of patching up damage—a bit like fixing a pothole. When skin is cut or a muscle is injured, fibroblast cells rush in to make fibronectin and collagen, which are two major extracellular matrix proteins ...
Apr 2, 2026
0
6
A new type of daily pill has proven more effective for weight loss and blood sugar control than its currently available counterparts, according to a recent trial. The drug, known as orforglipron, could be a game-changer in ...
Mar 25, 2026
0
9
A fall on the head, a blow to the skull, or a road traffic accident—the causes of traumatic brain injury are diverse, but the severe forms have a common denominator: immune reactions and inflammatory processes are added on ...
Mar 25, 2026
0
5
Using computational modeling, a research team has developed a novel peptide (MLPH) that promotes hair growth without the side effects of existing drugs. This achievement, accomplished through a joint research project led ...
Mar 24, 2026
0
9
Australian researchers have uncovered a critical mechanism driving the growth and spread of glioblastoma—one of the most aggressive and lethal forms of brain cancer—potentially paving the way for more effective treatments. ...
Mar 23, 2026
0
24
Around 20–40% of the general population are estimated to have insulin resistance—a condition where insulin begins to be less effective in the body, and glucose regulation becomes more difficult. Eventually, this can lead ...
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades. The most aggressive subtypes are a significant ...
Mar 16, 2026
0
10
Researchers from The University of Texas MD Anderson Cancer Center have found that simultaneously blocking two key "don't eat me signals" found in cancer cells heightens the immune response and sensitizes tumors to immunotherapy ...
Mar 13, 2026
0
5
